Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Incobotulinum Toxin A (Xeomin®) As A Treatment For Focal Task-Specific Dystonia Of The Musician's Hand

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02107261
Recruitment Status : Recruiting
First Posted : April 8, 2014
Last Update Posted : November 5, 2018
Sponsor:
Collaborator:
Merz North America, Inc.
Information provided by (Responsible Party):
David M. Simpson, Icahn School of Medicine at Mount Sinai

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2019
  Estimated Study Completion Date : July 2019
Publications: